Stem Cell Transplants for Early MS: Who Benefits Most? 🔗 Access full article via Medscape NeurologyResearchers are exploring HSCT as a rescue therapy in early-stage MS. But there’s no consensus on best practices. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
